Correction to: Probiotics and Antimicrobial Proteins (2018)

https://doi.org/10.1007/s12602-018-9401-3

The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below:

  • On page 6, right column line 4, SIBO should read IBS-C.

  • Figure 4, the legend of panel (d) should read IBS-M(+) (n = 10).

  • Figure 5, the legend of panel (b) should read IBS-M(+) (n = 10).

Fig. 4
figure 1

Effect of treatment with the studied preparation of four probiotics on the components of the IBS Severity Scoring System. a, b Percent change of scoring for bowel satisfaction and for the effect of bowel function on daily life in relation to the absence or presence of small intestinal bacterial overgrowth (SIBO). c Percent change of scoring for bowel function satisfaction in relation to the presence of diarrhea predominant IBS (IBD-D). d Percent change of abdominal pain intensity in relation to the presence of mixed-type IBS (IBD-M). The p values of statistically significant comparisons are shown

Full size image
Fig. 5
figure 2

Effect of treatment with the studied preparation of four probiotics on the stool form and on the days of work loss. a Rate of patients with normal stool in relation to the presence of constipation-predominant IBS (IBS-C). Normal stool is considered as any Bristol stool scale of 4 or 5. b Decrease of the days ofwork loss compared to the period before treatment in relation to the presence of mixed-type IBS (IBS-M). The p values of statistically significant comparisons are shown. CI. confidence interval

Full size image

The authors apologize for potential issues raised by these mistakes.